PULMONARY EMBOLISM
Detailed Nursing Notes + NORCET High-Yield Points
Clinical Concepts + Nursing Management + Quick Revision
25 Case/Concept-Based MCQs | 30-Minute Test
1. Introduction
Pulmonary embolism (PE) is obstruction of a pulmonary artery or one of its branches, most commonly caused by a thrombus that has traveled from the venous circulation, particularly from a deep vein thrombosis (DVT) of the lower extremities or pelvis.
Pulmonary embolism is obstruction of pulmonary arterial blood flow by an embolus, most commonly a thrombus originating from the deep veins of the legs or pelvis.
PE is part of the clinical spectrum known as venous thromboembolism (VTE), which includes DVT and PE.
A large or hemodynamically significant pulmonary embolism can cause acute right ventricular failure, obstructive shock and cardiac arrest.
2. DVT → Pulmonary Embolism Concept
| Step | Process |
|---|---|
| 1 | Venous thrombus forms, commonly in the deep veins of the leg or pelvis. |
| 2 | A portion of the thrombus may detach. |
| 3 | The embolus travels through the venous circulation. |
| 4 | It reaches the right side of the heart. |
| 5 | It enters the pulmonary circulation. |
| 6 | It obstructs pulmonary blood flow. |
| 7 | Gas exchange and right ventricular function may become impaired. |
DVT → Clot Travels → Pulmonary Artery → PE
3. Types / Clinical Severity
A. Non-Massive / Hemodynamically Stable PE
The patient does not have persistent hypotension or shock. Management is guided by clinical probability, imaging, risk assessment and bleeding risk.
B. Intermediate-Risk PE
Patients may remain normotensive but have evidence suggesting right ventricular strain or myocardial injury and require closer monitoring.
C. High-Risk / Massive PE
Severe PE may cause persistent hypotension, obstructive shock or cardiac arrest.
Massive/high-risk PE is primarily recognized by hemodynamic instability, not simply by the size of the clot.
4. Causes and Risk Factors
Major Risk Factors
- Deep vein thrombosis
- Recent major surgery
- Prolonged immobilization
- Long-distance travel with prolonged immobility
- Hospitalization
- Previous VTE
- Active cancer
- Pregnancy and postpartum state
- Estrogen-containing hormonal therapy
- Obesity
- Smoking
- Advanced age
- Major trauma
- Fractures, especially major lower-limb fractures
- Inherited or acquired thrombophilia
Virchow's Triad
The development of venous thrombosis is classically explained by Virchow's triad.
| Component | Examples |
|---|---|
| Venous stasis | Immobility, prolonged bed rest, long travel |
| Endothelial injury | Surgery, trauma, vascular injury |
| Hypercoagulability | Cancer, pregnancy, thrombophilia, estrogen exposure |
Virchow = Stasis + Vessel wall injury + Hypercoagulability
5. Pathophysiology
- A thrombus forms in the venous circulation.
- Part of the thrombus may detach.
- The embolus travels to the pulmonary circulation.
- Pulmonary arterial blood flow becomes obstructed.
- Ventilation-perfusion mismatch develops.
- Some areas of the lung may be ventilated but poorly perfused.
- Pulmonary vascular resistance increases.
- The right ventricle has to pump against increased resistance.
- Right ventricular strain or failure may develop in severe PE.
- Cardiac output may fall.
- Severe obstruction can produce obstructive shock.
Pulmonary vascular obstruction → ↑ pulmonary vascular resistance → right ventricular strain → ↓ left ventricular filling → ↓ cardiac output → hypotension/shock.
6. Clinical Manifestations
Common Symptoms
- Sudden unexplained dyspnea
- Chest pain
- Rapid breathing
- Tachycardia
- Anxiety or sense of impending doom
- Hypoxemia
- Cough
- Hemoptysis may occur, particularly with pulmonary infarction
Severe PE
- Severe respiratory distress
- Hypotension
- Syncope
- Altered mental status
- Signs of right ventricular failure
- Obstructive shock
- Cardiac arrest
Possible DVT Findings
- Unilateral leg swelling
- Leg pain or tenderness
- Warmth
- Redness
Sudden unexplained dyspnea + tachycardia + pleuritic chest pain, especially in a patient with VTE risk factors, should raise suspicion for PE.
7. Diagnostic Evaluation
1. Clinical Probability Assessment
Clinical prediction tools such as the Wells score may be used to estimate pretest probability and guide further testing.
2. D-Dimer
D-dimer is a sensitive marker of fibrin degradation. In appropriately selected patients with low or intermediate clinical probability, a negative D-dimer may help exclude PE.
A positive D-dimer is not specific for PE and can occur in many other conditions, including infection, inflammation, pregnancy, cancer and after surgery.
3. CT Pulmonary Angiography — CTPA
CT pulmonary angiography is a major imaging test used to confirm or exclude PE in many clinically appropriate patients.
4. Ventilation-Perfusion Scan
A V/Q scan may be used when CT pulmonary angiography is unsuitable or in selected clinical situations.
5. ECG
ECG may show abnormalities such as sinus tachycardia. The classic S1Q3T3 pattern may occur but is neither sensitive nor specific for PE.
6. Arterial Blood Gas
ABG may show hypoxemia and respiratory alkalosis due to hyperventilation, although findings vary and a normal PaO₂ does not exclude PE.
7. Echocardiography
Echocardiography can assess right ventricular strain and is particularly useful in evaluating unstable patients.
8. Venous Doppler Ultrasound
Lower-limb venous ultrasound may identify DVT when suspected.
8. Medical Management
A. Anticoagulation
Anticoagulation is the main treatment for most confirmed PE when there is no contraindication.
Common anticoagulant strategies include heparin-based therapy and direct oral anticoagulants in appropriate patients.
B. Thrombolytic Therapy
Systemic thrombolysis may be considered in selected patients with high-risk PE and hemodynamic instability when the benefits outweigh the bleeding risk.
Thrombolytic therapy is generally associated with high-risk/hemodynamically unstable PE, not routine stable PE.
C. Catheter-Based Therapy
Selected patients may undergo catheter-directed thrombectomy or thrombolytic therapy depending on clinical severity, bleeding risk, resources and specialist expertise.
D. Surgical Embolectomy
Surgical removal of the embolus may be considered in selected patients when other reperfusion strategies are unsuitable or unsuccessful.
E. Inferior Vena Cava Filter
An IVC filter may be considered in selected patients with acute VTE when anticoagulation is contraindicated or in certain situations of recurrent embolism despite appropriate treatment.
F. Oxygen and Supportive Management
- Provide oxygen when clinically indicated.
- Monitor respiratory status.
- Support blood pressure in unstable patients.
- Manage pain appropriately.
- Continuous monitoring may be required in severe PE.
9. Nursing Management
A. Immediate Assessment
- Assess airway, breathing and circulation.
- Monitor respiratory rate.
- Monitor oxygen saturation.
- Assess heart rate and blood pressure.
- Assess level of consciousness.
- Assess chest pain.
B. Oxygenation
- Administer oxygen as prescribed/clinically indicated.
- Monitor response to oxygen therapy.
- Observe for increasing respiratory distress.
C. Cardiovascular Monitoring
- Monitor ECG when indicated.
- Monitor blood pressure.
- Observe for hypotension.
- Assess peripheral perfusion.
- Watch for signs of shock.
D. Anticoagulant Safety
- Administer anticoagulants exactly as prescribed.
- Monitor for bleeding.
- Observe gums, urine, stool and skin for bleeding.
- Monitor relevant laboratory tests when required by the medication.
- Avoid unnecessary invasive procedures when bleeding risk is high.
E. Activity
Activity recommendations depend on clinical stability and treatment plan. Avoid unnecessary exertion during acute instability.
F. Psychological Support
- Remain calm and reassure the patient.
- Explain procedures clearly.
- Reduce anxiety.
- Provide emotional support.
10. Anticoagulants — Nursing Responsibilities
| Drug/Class | Important Nursing Considerations |
|---|---|
| Unfractionated Heparin | Monitor appropriate coagulation parameters according to protocol; monitor platelets and bleeding. |
| LMWH | Administer correctly; monitor bleeding and special populations as clinically indicated. |
| Warfarin | Requires INR monitoring; has important food/drug interactions. |
| DOACs | Monitor adherence, renal/hepatic considerations where relevant and signs of bleeding. |
Heparin and other anticoagulants prevent clot extension and new clot formation; they do not directly dissolve an established clot like thrombolytic therapy.
11. Prevention of DVT and Pulmonary Embolism
Hospitalized Patients
- Early mobilization when clinically appropriate.
- Leg exercises for patients who cannot ambulate.
- Appropriate hydration according to clinical condition.
- Mechanical prophylaxis when indicated.
- Pharmacological thromboprophylaxis when prescribed.
Postoperative Patients
- Encourage early mobilization.
- Use prescribed compression devices.
- Administer prophylactic anticoagulants when ordered.
- Monitor for DVT symptoms.
Travel-Related Risk
During prolonged travel, appropriate movement and leg exercises can help reduce venous stasis in people at risk.
12. Complications
- Right ventricular failure
- Obstructive shock
- Hypoxemic respiratory failure
- Cardiac arrest
- Pulmonary infarction
- Recurrent PE
- Chronic thromboembolic pulmonary hypertension
- Death in severe untreated cases
13. Massive / High-Risk Pulmonary Embolism
PE + persistent hypotension/shock = high-risk PE requiring urgent resuscitation and consideration of reperfusion therapy.
Possible Findings
- Severe dyspnea
- Hypotension
- Syncope
- Tachycardia
- Hypoxemia
- Elevated JVP/right-sided pressure signs
- Right ventricular dysfunction
- Cardiac arrest
Priority
ABC stabilization + oxygenation + hemodynamic support + urgent definitive PE management.
14. Pulmonary Embolism vs Myocardial Infarction
| Feature | Pulmonary Embolism | Myocardial Infarction |
|---|---|---|
| Primary problem | Pulmonary arterial obstruction | Coronary arterial obstruction |
| Typical symptom | Sudden dyspnea, pleuritic chest pain | Pressure/heaviness chest pain, often prolonged |
| Risk factor | DVT/VTE risk factors | Coronary artery disease risk factors |
| ECG | Often nonspecific; sinus tachycardia common | May show ischemic changes depending on infarction |
| Major severe complication | Right ventricular failure/obstructive shock | Left ventricular failure/arrhythmia/cardiogenic shock |
Clinical presentation can overlap. Do not diagnose PE or MI from one symptom or one ECG finding alone.
15. NORCET High-Yield Points
- Most PE originates from venous thromboembolism, especially DVT.
- Sudden unexplained dyspnea is an important presentation.
- Tachycardia is common.
- Pleuritic chest pain may occur.
- Hemoptysis can occur, especially with pulmonary infarction.
- Major VTE risk factors include immobility, surgery, cancer, pregnancy, previous VTE and thrombophilia.
- Virchow triad = stasis + endothelial injury + hypercoagulability.
- D-dimer is useful mainly in appropriately selected patients with lower pretest probability.
- A positive D-dimer does not confirm PE.
- CT pulmonary angiography is a major diagnostic imaging test.
- S1Q3T3 is neither sensitive nor specific for PE.
- Anticoagulation is the main treatment for most confirmed PE when not contraindicated.
- Thrombolysis is considered mainly for selected high-risk PE with hemodynamic instability.
- Severe PE can cause right ventricular failure.
- Severe PE can cause obstructive shock.
- PE can cause cardiac arrest.
- Early mobilization is an important component of VTE prevention when clinically appropriate.
16. Quick Revision — One-Minute Recall
| Question | Answer |
|---|---|
| What is PE? | Obstruction of pulmonary arterial circulation by an embolus. |
| Most common source? | Deep veins of the lower limbs/pelvis. |
| Major precursor? | DVT. |
| Common symptom? | Sudden dyspnea. |
| Common vital-sign finding? | Tachycardia. |
| Important chest pain type? | Pleuritic chest pain. |
| Three components of Virchow triad? | Stasis, endothelial injury, hypercoagulability. |
| Important diagnostic imaging? | CT pulmonary angiography. |
| Useful blood test in selected patients? | D-dimer. |
| Main treatment? | Anticoagulation when appropriate. |
| Emergency severe PE treatment? | Resuscitation and consideration of reperfusion therapy in high-risk PE. |
| Major severe complication? | Right ventricular failure and obstructive shock. |
DVT → CLOT TRAVELS → PULMONARY ARTERY → PE → HYPOXEMIA / RV STRAIN
17. NORCET MCQ Practice Test
- 25 questions
- 30-minute timer
- One question at a time
- Select one best answer
- Previous / Next navigation
- Automatic submission when time expires
- Score and explanations after submission
18. Important Note
These notes are intended for nursing education and examination preparation. Pulmonary embolism can be life-threatening. Actual diagnosis and treatment must be based on the patient's clinical condition, current evidence-based guidelines, institutional protocols and the treating healthcare team's assessment.
Medical & Nursing Education | NORCET Preparation
Study • Practice • Revise • Improve